<i>Astragalus membranaceus</i> and<i> Salvia miltiorrhiza</i> Ameliorate Lipopolysaccharide-Induced Acute Lung Injury in Rats by Regulating the Toll-Like Receptor 4/Nuclear Factor-Kappa B Signaling Pathway

<div>Schematic plot of the possible mechanisms behind the protective and therapeutic effects of AM/SM on LPS-induced ALI. AM/SM downregulated the TLR-4/IRAK-1/NF-<i>κ</i>B signaling pathway; then inflammatory cytokines were decreased. Pulmonary edema and lung tissue damage were alleviated at last.</div>

Evidence-Based Complementary and Alternative Medicine

fig7

Figure 7

Figure 7: <i>Astragalus membranaceus</i> and<i> Salvia miltiorrhiza</i> Ameliorate Lipopolysaccharide-Induced Acute Lung Injury in Rats by Regulating the Toll-Like Receptor 4/Nuclear Factor-Kappa B Signaling Pathway 

Figure 7 | Astragalus membranaceus and Salvia miltiorrhiza Ameliorate Lipopolysaccharide-Induced Acute Lung Injury in Rats by Regulating the Toll-Like Receptor 4/Nuclear Factor-Kappa B Signaling Pathway 